Outcome of Resection for Colorectal Cancer
Not Applicable
- Conditions
- Laparoscopy
- First Posted Date
- 2019-02-12
- Last Posted Date
- 2019-02-12
- Target Recruit Count
- 1300
- Registration Number
- NCT03837782
- Locations
- 🇨🇳
Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin, China
The MDA Test to Differentiate of Benign and Malignant Pulmonary Nodules
- Conditions
- Pulmonary Nodule, Solitary
- First Posted Date
- 2019-01-02
- Last Posted Date
- 2019-01-02
- Target Recruit Count
- 200
- Registration Number
- NCT03790735
- Locations
- 🇨🇳
Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
Adjuvant Chemotherapy for Biliary Tract Cancer After Curative Resection
Phase 3
- Conditions
- CholangiocarcinomaGall Bladder Carcinoma
- Interventions
- First Posted Date
- 2018-12-19
- Last Posted Date
- 2018-12-19
- Target Recruit Count
- 460
- Registration Number
- NCT03779035
- Locations
- 🇨🇳
Tianjin Medical University Cancer Insititute and Hospital, Tianjin, Tianjin, China
A Efficacy and Safety Study of Composite Gel Containing Black Raspberry Extract in Removing HPV From Patients With Cervical Intraepithelial Neoplasia(CIN) After Cervical Conization
Phase 2
- Conditions
- HPVCervical Intraepithelial Neoplasia
- First Posted Date
- 2018-11-19
- Last Posted Date
- 2018-11-19
- Target Recruit Count
- 78
- Registration Number
- NCT03745846
Effect of Radiation and Its Timing on Breast Reconstruction in Chinese Patients
- Conditions
- Breast Cancer
- First Posted Date
- 2018-11-16
- Last Posted Date
- 2018-11-16
- Target Recruit Count
- 1344
- Registration Number
- NCT03743324
Application of Intra-operative Prophylactic Antibiotics/Antiseptics in Chinese Breast Reconstruction Patients
Not Applicable
- Conditions
- Breast Neoplasms
- Interventions
- Drug: Cefazolin/clindamycin
- First Posted Date
- 2018-11-15
- Last Posted Date
- 2018-11-15
- Target Recruit Count
- 291
- Registration Number
- NCT03742908
- Locations
- 🇨🇳
Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin, China
Study of Anlotinib Combined With Icotinib as the First-line Treatment in Patients With EGFR Mutation-positive NSCLC
- First Posted Date
- 2018-11-09
- Last Posted Date
- 2021-03-15
- Target Recruit Count
- 60
- Registration Number
- NCT03736837
- Locations
- 🇨🇳
Hebei Provincial People's Hospital, Shijiazhuang, Hebei, China
🇨🇳Neimenggu Autonomous Region People's Hospital, Hohhot, Neimenggu, China
🇨🇳Neimenggu Medical University Affiliated Hospital, Hohhot, Neimenggu, China
A Study to Compare Efficacy and Safety of DRT VS CRT Plus Surgery in Patients Who Achieved CCR for Esophageal Cancer
Phase 3
- Conditions
- Stage II Esophageal CancerStage III Esophageal Cancer
- First Posted Date
- 2018-10-16
- Last Posted Date
- 2018-10-16
- Target Recruit Count
- 220
- Registration Number
- NCT03708042
Combination of Chemotherapy Plus RT and SHR-1210 to Treat Patients With ESCC
Not Applicable
- Conditions
- Esophageal Cancer
- Interventions
- First Posted Date
- 2018-09-14
- Last Posted Date
- 2019-01-09
- Target Recruit Count
- 20
- Registration Number
- NCT03671265
- Locations
- 🇨🇳
Department of Radiation Oncology, Tianjin Medical University Cancer Hospital, Tianjin, Tianjin, China
Comprehensive Analysis of Gene Mutation Profile in Chinese NSCLC Patients by Next-generation Sequencing
Completed
- Conditions
- NSCLC
- First Posted Date
- 2018-08-01
- Last Posted Date
- 2018-08-07
- Target Recruit Count
- 513
- Registration Number
- NCT03609918